What are the effects of vitamin B12 deficiency and its simple treatment?

Vitamin B12 Deficiency: Effects and Treatment

Vitamin B12 deficiency causes potentially irreversible neurological damage, macrocytic anemia, and cognitive dysfunction—early recognition and treatment with intramuscular B12 (1000 µg) is essential for severe cases, while oral supplementation works for mild dietary deficiency.

Clinical Effects of B12 Deficiency

Hematological Manifestations

• Macrocytic anemia with elevated mean corpuscular volume (MCV >100 fL) 1, 2
• Baseline hemoglobin typically drops to 9-10 g/dL in deficient patients 2
• Abnormal blood counts that fail to respond to iron supplementation 1

Neurological Consequences

The neurological effects are the most concerning because they can become irreversible if not treated promptly 3:

• Peripheral neuropathy: pins and needles, numbness, tingling in extremities (present in 54% of patients) 1, 2
• Spinal cord disease (myelopathy): impaired proprioception leading to balance problems, falls, and sensory ataxia 1
• Optic nerve dysfunction: blurred vision, visual field loss, optic atrophy 1
• Gait disturbances and mobility impairment 1

Neuropsychiatric Effects

B12 deficiency produces distressing mental symptoms 4:

• Cognitive impairment: "brain fog," difficulty concentrating, short-term memory loss 1
• Depression, anxiety, and psychosis 4
• Delirium and dementia-like presentations 4
• Apathy, agitation, insomnia, hallucinations (auditory and visual), delusions 4

General Symptoms

• Unexplained fatigue (present in 67% of patients) 1, 2
• Glossitis (inflamed tongue) 1

Who Is at Risk

Key risk factors to identify 1:

• Dietary: vegans, vegetarians, those avoiding animal products
• Medications: metformin, proton pump inhibitors, H2 blockers, colchicine 1, 5
• Malabsorption: atrophic gastritis, pernicious anemia, celiac disease, H. pylori infection 1
• Age: older adults have higher prevalence 5
• Autoimmune conditions: thyroid disease, type 1 diabetes, Sjögren syndrome 1

Diagnostic Approach

First-Line Testing

Test total serum B12 first when clinical suspicion exists based on symptoms plus risk factors 1, 5, 6:

• Deficient: <180 pg/mL (diagnostic) 5
• Borderline: 180-350 pg/mL (requires confirmatory testing) 5
• Normal: >350 pg/mL

Active B12 (holotranscobalamin) is more accurate but costs 9 times more (£18 vs £2) with longer turnaround times—the guideline does not recommend routine use despite theoretical advantages 1.

Confirmatory Testing

For borderline results, measure methylmalonic acid (MMA)—elevated MMA confirms functional B12 deficiency 1, 5. However, MMA costs £11-80 per test and can be elevated in renal disease 1.

Investigate the Cause

Once deficiency is confirmed 5:

• Test for H. pylori
• Check for autoantibodies associated with autoimmune gastritis
• Review medication list and dietary history

Treatment Strategy

Severe Deficiency or Neurological Symptoms

Use intramuscular hydroxocobalamin 1000 µg 5, 3, 7:

• Loading phase: 1000 µg IM once weekly for 6 weeks 2
• Maintenance: 1000 µg IM every 2 months per British National Formulary 3
• Critical caveat: Up to 50% of patients require individualized, more frequent dosing (ranging from twice weekly to every 2-4 weeks) to remain symptom-free 3
• Do NOT titrate injection frequency based on serum B12 or MMA levels—use clinical symptoms instead 3

Mild Deficiency Without Neurological Symptoms

Oral B12 supplementation is noninferior to IM for most patients without severe manifestations 5:

• High-dose oral B12 (typically 1000-2000 µg daily) can be used 7
• Requires adequate absorption capacity—not suitable for malabsorption syndromes 3

Expected Response

Treatment produces rapid improvements 2:

• Hemoglobin rises from ~9.7 to 12.6 g/dL by 6 weeks
• MCV normalizes from ~105 to 91 fL
• Reticulocyte count increases (indicating bone marrow response)
• Strong correlation exists between B12 levels and hemoglobin improvement (r=0.75) 2

Critical Pitfalls

1. Neurological damage can be permanent if treatment is delayed—always treat urgently when neurological symptoms are present 3

2. Oral supplementation may be insufficient in malabsorption—parenteral route is preferred for pernicious anemia, gastric surgery, or severe malabsorption 3

3. Standard maintenance dosing fails in many patients—clinical symptoms should guide frequency, not lab values 3

4. Persistently elevated B12 levels (>1000 pg/mL on two measurements) associate with solid tumors, hematologic malignancy, and cardiovascular death—investigate if this occurs 5

5. Don't rely solely on lab values—clinical symptoms should receive highest priority in diagnosis and treatment monitoring 7